2 studies found for:    15276396 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 11 to 55 Years of Age in the Republic of South Korea
Condition: Meningococcal Disease
Intervention: Biological: Novartis Meningococcal ACWY Conjugate Vaccine (Menveo)
2 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Children, Adolescents and Adults in Russia
Condition: Meningococcal Disease
Intervention: Biological: MenACWY-CRM

Indicates status has not been verified in more than two years